The goal of treatment for mild cerebral infarction is to implement reperfusion therapy as early as possible while actively treating the primary disease. It is not possible to assess whether thrombolysis or conventional therapy is better. In the presence of a mild cerebral infarction, there is a need for early salvage of the ischemic semidomain to avoid or mitigate primary brain injury. Within the time window for thrombolysis (within 4.5 hours of onset), patients who exclude contraindications can undergo intravenous thrombolysis as prescribed by their physician, with recombinant tissue-type activator of fibrinolytic enzymes being the most commonly used drug. In addition, vascular intervention can be used to remedy the lack of effectiveness of intravenous access. At the same time, for the onset of a longer period of time, has exceeded the time window of thrombolysis, patients who are not suitable for thrombolysis, need to carry out conventional treatment, such as antiplatelet aggregation therapy, anticoagulation therapy, improve circulation, cerebral protection therapy, and so on. If a mild cerebral infarction occurs, do not use drugs on your own. You need to seek medical attention as soon as possible to avoid serious complications.